Neola Medical AB (publ) (NEOLA.ST)
SEK 2.4
(-4.76%)
SEK 2.4
(-4.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.54 Million | -8.49 Million | -6.93 Million | -6.07 Million | -2.06 Million | -1.31 Million |
| Net Income | -9.01 Million | -10.35 Million | -6.65 Million | -6.71 Million | -2.6 Million | -761 Thousand |
| Depreciation & Amortization | 1.43 Million | 571 Thousand | 15 Thousand | 7000.00 | 7000.00 | 7000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 640 Thousand | 759 Thousand | -300 Thousand | 658 Thousand | 533 Thousand | -564 Thousand |
| Other non-cash items | 2.59 Million | 1.17 Million | 769 Thousand | -344 Thousand | -520 Thousand | 577 Thousand |
| Investing Cash Flow | -12.3 Million | -11.55 Million | -10.51 Million | -2.17 Million | -2.43 Million | -1.35 Million |
| Investments in PPE | -12.3 Million | -11.55 Million | -10.51 Million | -2.17 Million | -2.43 Million | -1.35 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -12.3 Million | - | - | - | - | - |
| Financing Cash Flow | 336 Thousand | 37.2 Million | 23.74 Million | 19.54 Million | - | 10 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 336 Thousand | 37.2 Million | 23.74 Million | 19.54 Million | - | 10 Million |
| Other Financing Activities | -168 Thousand | - | - | - | - | - |
| Accounts receivables | -16 Thousand | 362 Thousand | -1.06 Million | -281 Thousand | -298 Thousand | -45 Thousand |
| Accounts payables | 686 Thousand | 159 Thousand | 336 Thousand | 616 Thousand | 831 Thousand | -519 Thousand |
| Inventory | - | -27 Thousand | - | - | - | - |
| Other working capital | -30 Thousand | 265 Thousand | 432 Thousand | 323 Thousand | - | - |
| Cash at beginning of period | 40.08 Million | 22.93 Million | 16.64 Million | 5.35 Million | 9.86 Million | 2.53 Million |
| Cash at end of period | 21.57 Million | 40.08 Million | 22.93 Million | 16.64 Million | 5.35 Million | 9.86 Million |
| Capital Expenditure | -12.3 Million | -11.55 Million | -10.51 Million | -2.17 Million | -2.43 Million | -1.35 Million |
| Effect of forex changes on cash | - | 22.93 Million | 16.64 Million | -1000.00 | 1000.00 | - |
| Net cash flow / Change in cash | -18.51 Million | 17.15 Million | 6.29 Million | 11.29 Million | -4.5 Million | 7.32 Million |
| Free Cash Flow | -18.84 Million | -20.05 Million | -17.44 Million | -8.25 Million | -4.5 Million | -2.67 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.82 Million | -2.32 Million | -1.95 Million | -9.01 Million | -2.36 Million | -2.4 Million |
| Depreciation & Amortization | 399 Thousand | 399 Thousand | 403 Thousand | 1.43 Million | 397 Thousand | 397 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 333 Thousand | -478 Thousand | 427 Thousand | 640 Thousand | 684 Thousand | -93 Thousand |
| Other non-cash items | 2.76 Million | 724 Thousand | 1.13 Million | 2.59 Million | 769 Thousand | 769 Thousand |
| Investing Cash Flow | 392 Thousand | -3.88 Million | -3.92 Million | -12.3 Million | -2.39 Million | -2.89 Million |
| Investments in PPE | - | - | - | -12.3 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.49 Million | - | - | - | - | - |
| Financing Cash Flow | -19.86 Million | 19.93 Million | -312 Thousand | 336 Thousand | 144 Thousand | 504 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 336 Thousand | - | - |
| Other Financing Activities | 68 Thousand | - | - | - | - | - |
| Accounts receivables | - | - | - | -16 Thousand | - | - |
| Accounts payables | - | - | - | 686 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -145 Thousand | - | - | -30 Thousand | - | - |
| Cash at beginning of period | 35.14 Million | 21.57 Million | 26.61 Million | 40.08 Million | 30.17 Million | 34.68 Million |
| Cash at end of period | 29.11 Million | 35.14 Million | 21.57 Million | 21.57 Million | 26.61 Million | 30.17 Million |
| Capital Expenditure | - | - | - | -12.3 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.03 Million | 13.56 Million | -5.03 Million | -18.51 Million | -3.56 Million | -4.5 Million |
| Free Cash Flow | -132 Thousand | -2.47 Million | -795 Thousand | -18.84 Million | -1.31 Million | -2.12 Million |
NOHO
2970
INDV
3430
6038
PMJS